Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Gliclazide MR and Basal Insulin vs Premix Insulin in Type 2 Diabetes
NCT00736515Phase 4Completed
- Sponsor
- Servier
- Start
- Oct 2008
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gliclazide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Servier. Primary endpoints: Fasting Plasma Glucose at 3 months, Glycated Hemoglobin at 3 months and 2 more. Started Oct 2008; status: completed.
02
Drugs
gliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00736515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00736515.